These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22129871)

  • 1. [Proposal to sports pharmacist as a sports doctor].
    Uchida A
    Yakugaku Zasshi; 2011; 131(12):1751-3. PubMed ID: 22129871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specialist pharmacist training from the viewpoint of sports pharmacology].
    Kasashi K
    Yakugaku Zasshi; 2012; 132(12):1325-8. PubMed ID: 23208035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Educational opportunities and anti-doping roles and responsibilities for pharmacists.
    Ambrose PJ
    Yakugaku Zasshi; 2011; 131(12):1761-4. PubMed ID: 22129874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey.
    Shibata K; Ichikawa K; Kurata N
    BMC Res Notes; 2017 Aug; 10(1):396. PubMed ID: 28800770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Why Did the Sports Pharmacists Create the Card Game?].
    Shimizu M
    Yakugaku Zasshi; 2022; 142(2):115-121. PubMed ID: 35110446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-doping reference for pharmacists].
    Kasashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1475-81. PubMed ID: 19952525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of the role of the sports pharmacist with a model for the prediction of athletes' actions to cope with sickness].
    Yamaguchi T; Horio I; Aoki R; Yamashita N; Tanaka M; Izushi F; Miyauchi Y; Araki H
    Yakugaku Zasshi; 2013; 133(11):1249-59. PubMed ID: 24189566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing anti-doping knowledge among Taiwanese pharmacists.
    Lee YC; Chen CY; Cheng YY; Hsu MC; Chen TT; Chang WC
    BMC Med Educ; 2023 Oct; 23(1):808. PubMed ID: 37891558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clarification of the Relationship between Awareness of Doping of Competitive Sports Coaches and Their Instructions to Prevent Doping].
    Yamaguchi T; Horio I; Goto M; Miyauchi Y; Izushi F
    Yakugaku Zasshi; 2016; 136(8):1185-93. PubMed ID: 27477736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engaging community pharmacists to eliminate inadvertent doping in sports: A study of their knowledge on doping.
    Voravuth N; Chua EW; Tuan Mahmood TM; Lim MC; Wan Puteh SE; Safii NS; Wong JE; Jamil AT; Jamal JA; Shamsuddin AF; Mhd Ali A
    PLoS One; 2022; 17(6):e0268878. PubMed ID: 35687540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists supporting athletes: a scoping review exploring the knowledge, role and responsibilities of pharmacists in preventing the unintentional use of prohibited substances by athletes.
    Greenbaum DH; McLachlan AJ; Roubin RH; Chaar BB
    Int J Pharm Pract; 2022 May; 30(2):108-115. PubMed ID: 35262700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-doping from the Perspective of a Pharmacist and an Athlete].
    Okazaki S
    Yakugaku Zasshi; 2022; 142(2):103-107. PubMed ID: 35110444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective of pharmacists in Qatar regarding doping and anti-doping in sports.
    Mottram D; Khalifa S; Alemrayat B; Rahhal A; Ahmed A; Stuart M; Awaisu A
    J Sports Med Phys Fitness; 2016 Jun; 56(6):817-24. PubMed ID: 25784399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-doping Activities and Comprehensive Health Support for Young Athletes].
    Nakajima R
    Yakugaku Zasshi; 2022; 142(2):123-128. PubMed ID: 35110447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-doping Activities by Hospital Pharmacists].
    Muraki Y
    Yakugaku Zasshi; 2022; 142(2):109-113. PubMed ID: 35110445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What the Japan Cycling Federation hopes to accomplish in cooperation with pharmacists in doping and implementing effective anti-doping controls?].
    Sakamoto Y
    Yakugaku Zasshi; 2011; 131(12):1747-9. PubMed ID: 22129870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sports physicians, ethics and antidoping governance: between assistance and negligence.
    Dikic N; McNamee M; Günter H; Markovic SS; Vajgic B
    Br J Sports Med; 2013 Jul; 47(11):701-4. PubMed ID: 23322892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.